SAIZEN Safety Questions, SAIZEN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about SAIZEN. Our extensive database of SAIZEN adverse events and SAIZEN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about SAIZEN
SAIZEN Safety Reports
Total SAIZEN reports: 39.SAIZEN FDA safety alerts: No.
Reported deaths: 7 Reported hospitalizations: 19.
Take SAIZEN Side Effects Survey or Share Your SAIZEN Story. SAIZEN Usage.
Physician from UNITED STATES reported SAIZEN problem on Jan 02, 2007. Female patient, child 3 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. SAIZEN dosage: 0.5 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with SYNTHROID, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Physician from GERMANY on Feb 09, 2007. Male patient, 13 years of age, weighting 92.59 lb, was diagnosed with body height below normal and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, headache, intraocular pressure increased, nausea. SAIZEN dosage: 2 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with CYCLOSPORINE, METHYLPREDNISOLONE, CELLCEPT, NEPHROTRANS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported SAIZEN problem on Feb 27, 2007. Male patient, child 10 years of age, weighting 64.15 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: germ cell cancer, malignant pituitary tumour. SAIZEN dosage: unknown. During the same period patient was treated with DESMOPRESSIN, LEVOTHYROXINE, MONTELUKAST, FLUTICASONE PROPIONATE, SALBUTAMOL. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Health Professional from UNITED STATES on Mar 12, 2007. Female patient, child 11 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: mass. SAIZEN dosage: 8.8 MG, NOT REPORTED, NOT REPORTED. Patient recovered.
Physician from TURKEY reported SAIZEN problem on Mar 20, 2007. Male patient, child 10 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: cerebral hypoperfusion, tourette's disorder. SAIZEN dosage: 0.03 MG/KG, 1 IN 1 DAYS;. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from AUSTRALIA on Mar 29, 2007. Female patient, child 6 years of age, weighting 35.27 lb, was diagnosed with blood growth hormone and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: ear infection, pharyngitis, tooth disorder, weight decreased. SAIZEN dosage: 3.4 MG, 1 IN 1 DAYS, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported SAIZEN problem on Mar 30, 2007. Male patient, child 10 years of age, weighting 64.15 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: germ cell cancer, pituitary enlargement. SAIZEN dosage: unknown. During the same period patient was treated with DESMOPRESSIN, LEVOTHYROXINE, MONTELUKAST, FLUTICASONE PROPIONATE, SALBUTAMOL. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2007. Male patient, 13 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: procedural complication. SAIZEN dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported SAIZEN problem on Apr 13, 2007. Female patient, child 4 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. SAIZEN dosage: 0.5 MG, 1 IN 1 DAYS, SUBCUTANEOUS. Patient died.
SAIZEN problem was reported by a Physician from SWEDEN on Apr 17, 2007. Male patient, child 8 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: brain neoplasm. SAIZEN dosage: 0.6 MG, 1 IN 1 DAYS, SUBCUTANEOUS. Patient recovered.
Health Professional from UNITED STATES reported SAIZEN problem on Apr 27, 2007. Female patient, child 3 years of age, weighting 31.31 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. SAIZEN dosage: 0.5 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with SYNTHROID, DDAVP, CORTEF, BICITRA. Patient died.
SAIZEN problem was reported by a Health Professional from UNITED STATES on Apr 25, 2007. Male patient, 13 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: no adverse effect. SAIZEN dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported SAIZEN problem on May 03, 2007. Female patient, child 3 years of age, weighting 31.31 lb, was diagnosed with blood growth hormone decreased and was treated with SAIZEN. SAIZEN dosage: 0.5 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with SYNTHROID, DDAVP, CORTEF, BICITRA. Patient died.
SAIZEN problem was reported by a Consumer or non-health professional from SWEDEN on May 03, 2007. Female patient, 13 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: erysipelas, pharyngolaryngeal pain. SAIZEN dosage: 1.5 MG, 1 IN 1 DAYS. Patient was hospitalized. Patient recovered.
Health Professional from CANADA reported SAIZEN problem on May 07, 2007. Male patient, 15 years of age, was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: fall, haematoma. SAIZEN dosage: unknown. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Physician from UNITED STATES on May 08, 2007. Male patient, child 10 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: blast cells present, bone pain, leukaemia, pyrexia. SAIZEN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported SAIZEN problem on June 12, 2007. Male patient, 16 years of age, weighting 74.30 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, weight decreased. SAIZEN dosage: unknown. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2007. Male patient, 13 years of age, weighting 99.21 lb, was diagnosed with noonan syndrome and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiomegaly, coronary artery disease, left ventricular hypertrophy, myocardial ischaemia. SAIZEN dosage: unknown. Patient died on 05/04/2007.
Physician from FRANCE reported SAIZEN problem on June 15, 2006. Male patient, 16 years of age, weighting 183.6 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: carpal tunnel syndrome. SAIZEN dosage: 1.6 MG, 1 IN 1 DAYS, SUBCUTANEOUS. Patient recovered.
SAIZEN problem was reported by a Physician from FRANCE on July 24, 2006. Male patient, 16 years of age, weighting 183.6 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: carpal tunnel syndrome. SAIZEN dosage: 1.6 MG, 1 IN 1 DAYS,. Patient recovered.
Health Professional from UNITED KINGDOM reported SAIZEN problem on Aug 23, 2006. Female patient was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: fall, headache. SAIZEN dosage: 0.6 MG, 1 IN 1 DAYS. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Health Professional from UNITED KINGDOM on Sept 01, 2006. Female patient, child 9 years of age, weighting 48.28 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: fall, headache. SAIZEN dosage: 0.6 MG, 1 IN 1 DAYS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from BRAZIL reported SAIZEN problem on Aug 09, 2006. Female patient was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: convulsion. SAIZEN dosage: unknown. Patient recovered.
SAIZEN problem was reported by a Physician from UNITED STATES on Sept 12, 2006. Female patient, child 4 years of age, was diagnosed with off label use and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: off label use, subvalvular aortic stenosis. SAIZEN dosage: 0.75 MG, 1 IN 1 DAYS, SUBCUTANEOUS. Patient recovered.
Physician from FRANCE reported SAIZEN problem on Sept 13, 2006. Female patient, 56 years of age, weighting 174.2 lb, was diagnosed with hypopituitarism, hypertriglyceridaemia, osteopenia, depression and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: angiopathy, bacterial infection, brain oedema, c-reactive protein increased, confusional state, headache, herpes simplex, meningism, meningitis. SAIZEN dosage: 0.8 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with HYDROCORTISONE, KLIOGEST, LEVOTHYROXINE, FENOFIBRATE, OROCAL D, PROZAC, ACYCLOVIR. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Physician from AUSTRALIA on Oct 05, 2006. Male patient, 14 years of age, weighting 72.75 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: arthralgia, osteonecrosis. SAIZEN dosage: 1.05 MG, 7 IN 1 WEEKS, SUBCUTANEOUS. Patient recovered.
Consumer or non-health professional from SWEDEN reported SAIZEN problem on Oct 11, 2006. Male patient, 16 years of age, weighting 143.3 lb, was diagnosed with ill-defined disorder and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: iron deficiency anaemia. SAIZEN dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Physician from FRANCE on Oct 17, 2006. Female patient, 49 years of age, weighting 158.7 lb, was diagnosed with hypopituitarism and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: marital problem, overdose, suicide attempt. SAIZEN dosage: 0.8 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with HYDROCORTISONE, LEVOTHYROXINE, CLIMASTON, ZOLPIDEM TARTRATE, ATORVASTATIN CALCIUM, BETASERC, PANTOPRAZOLE, ZOLOFT. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported SAIZEN problem on Nov 06, 2006. Female patient, 50 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: renal failure. SAIZEN dosage: unknown. During the same period patient was treated with CANDESARTAN. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from FRANCE on Nov 24, 2006. Male patient, 16 years of age, weighting 112.4 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: polyarthritis. SAIZEN dosage: 12.6 MG, 1 IN 1 WEEKS, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CANADA reported SAIZEN problem on Dec 05, 2006. Female patient, child 7 years of age, was treated with SAIZEN. SAIZEN dosage: 0.4 MG, 7 IN 1 WEEKS. Patient died.
SAIZEN problem was reported by a Health Professional from CANADA on Dec 07, 2006. Female patient, child 7 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: adrenocortical insufficiency acute, infection. SAIZEN dosage: 0.4 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with HYDROCORTISONE. Patient died on 02/28/2006.
Health Professional from UNITED STATES reported SAIZEN problem on Dec 07, 2006. Female patient, child 11 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: craniopharyngioma, neoplasm recurrence. SAIZEN dosage: unknown. During the same period patient was treated with HYDROCORTISONE, ATOMOXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from ITALY on June 27, 2007. Male patient, 18 years of age, was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: ameloblastoma, neoplasm recurrence. SAIZEN dosage: 1.33 MG, 1 IN 1 DAYS, SUBCUTANEOUS. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.
Physician from PORTUGAL reported SAIZEN problem on July 13, 2007. Male patient, child 9 years of age, weighting 61.73 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: haemangioma of liver. SAIZEN dosage: 0.84 MG, 7 IN 1 WEEKS, SUBCUTANEOUS. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2007. Female patient, child 7 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: economic problem, infection, injection site bruising, injection site haemorrhage, injection site reaction, treatment noncompliance. SAIZEN dosage: 0.2 ML. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported SAIZEN problem on Sept 10, 2007. Male patient, child 10 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, bone pain. SAIZEN dosage: unknown. Patient was hospitalized. Patient recovered.
SAIZEN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 11, 2007. Male patient, child 10 years of age, weighting 78.93 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: glucose tolerance impaired, glycosylated haemoglobin increased. SAIZEN dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported SAIZEN problem on Sept 20, 2007. Female patient, 48 years of age, was diagnosed with growth hormone deficiency and was treated with SAIZEN. SAIZEN dosage: 0.25 MG, 1 IN 1 DAYS,. Patient died.
This
drug has an active FDA Safety Alert